AwesomeCapital
Search This Blog
Tuesday, August 6, 2019
Flexion Therapeutics EPS beats by $0.09, beats on revenue
Flexion Therapeutics (NASDAQ:
FLXN
): Q2 GAAP EPS of -$0.96
beats by $0.09
.
Revenue of $16.95M (+347.2% Y/Y)
beats by $1.99M
.
Press Release
https://seekingalpha.com/news/3487865-flexion-therapeutics-eps-beats-0_09-beats-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.